
zzso have long been considered to be potential zzso agents because of their specificity for zzso zzso zzso of zzso and zzso DNA technology have led to the production of unlimited quantities of zzso zzso zzso and humanized zzso zzso for clinical zzso Whole zzso may produce zzso effects in conjunction with the immune system by interaction with complement proteins and/or zzso cells via the zzso portion of the zzso zzso zzso may also neutralize circulating zzso or block cell membrane receptors and thus interrupt zzso interactions and signal zzso that are associated with zzso or zzso zzso The zzso network cascade provides a rationale for zzso as vaccine zzso zzso may also serve as the guiding or targeting system for other zzso pharmaceutical products such as zzso zzso zzso for zzso and zzso zzso zzso zzso zzso zzso zzso zzso zzso and zzso immune zzso zzso After years of zzso as of late 1999 there were four zzso zzso that had been approved by the zzso Food and Drug Administration based on activity against human zzso all of which are in widespread clinical zzso Several other products are in various stages of clinical trial zzso zzso zzso have joined zzso zzso zzso and various zzso growth factors as well-established components of biological therapy, the fourth zzso of cancer zzso 

